New device IDs disease-causing germs

(HealthDay)—A new spectrometer system designed to identify 193 yeast and bacteria that are capable of making people sick has been approved by the U.S. Food and Drug Administration.

The Vitek MS can screen for yeasts such as Candida and Malassezia and bacteria from the Staphylococcaceae and pneumonia families, the agency said in a news release. People with AIDS and others with are most prone to infections from these germs.

The device uses a laser to break germs into pattern-forming particles that are unique to each or bacterium, the FDA said. Only a small amount is necessary to identify these germs, which collectively are responsible for skin, bloodstream and respiratory infections.

In clinical testing, the new device correctly identified a germ's scientific group or family more than 93 percent of the time, the agency said.

The Vitek MS is manufactured by bioMerieux Inc of Durham, N.C.

More information: The FDA has more about this approval.

Related Stories

Vibativ approved for certain bacterial pneumonia

date Jun 24, 2013

(HealthDay)—The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable.

Blood-tracking device uses new technology

date May 29, 2013

(HealthDay)—The first device to use Radio Frequency Identification (RFID) technology to help workers track blood products and prevent the release of unsuitable samples has been approved by the U.S. Food and Drug Administration.

New drugs, diagnostic approved for advanced melanoma

date May 29, 2013

(HealthDay)—Two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved by the U.S. Food and Drug Administration to treat advanced melanoma, the most dangerous form of skin cancer.

New test IDs genotype of hepatitis C

date Jun 20, 2013

(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

Kcentra approved to stop severe bleeding in heart patients

date Apr 30, 2013

(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...

Recommended for you

Genetic test for inherited kidney diseases developed

date 2 minutes ago

Many kidney disorders are difficult to diagnose. To address this problem, scientists and clinicians have developed a diagnostic test that identifies genetic changes linked to inherited kidney disorders. This ...

Diagnosing infectious diseases at the point-of-care

date 30 minutes ago

A major problem with current testing for infectious diseases in Africa is that it focuses on individual diseases and cannot reliably discriminate between them. Since most infectious diseases have the same ...

Fracture liaison services prevent fractures and save lives

date 55 minutes ago

Using a simulation model, Swedish researchers have shown that the implementation of Fracture Liaison Services (FLS) could considerably reduce the human and healthcare costs associated with osteoporotic fractures. The results ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.